This announcement is a separate document:
華康生物醫學：二零二三年第一季度報告
HUAKANG BIOMED: 2023 First Quarterly Report
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.